# Vitamin D Supplementation for the Prevention of Cardiovascular Risk

> **NCT02020694** · PHASE4 · COMPLETED · sponsor: **Fondazione Policlinico Universitario Agostino Gemelli IRCCS** · enrollment: 60 (actual)

## Conditions studied

- Obesity
- Overweight
- Insulin Resistance

## Interventions

- **DRUG:** Vitamin D
- **DRUG:** Placebo (for vitamin D)

## Key facts

- **NCT ID:** NCT02020694
- **Lead sponsor:** Fondazione Policlinico Universitario Agostino Gemelli IRCCS
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-12
- **Primary completion:** 2013-12
- **Final completion:** 2013-12
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2023-04-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02020694

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02020694, "Vitamin D Supplementation for the Prevention of Cardiovascular Risk". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02020694. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
